Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems
Abstract
:1. Introduction
2. Lung Involvement
3. Cardiovascular Involvement
4. Brain Involvement
5. Organ Crosstalk and Management of Post-COVID Conditions
6. Conclusions
Funding
Informed Consent Statement
Conflicts of Interest
References
- Scordo, K.A.; Richmond, M.M.; Munro, N. Post-COVID-19 Syndrome: Theoretical Basis, Identification, and Management. AACN Adv. Crit. Care 2021, 32, 188–194. [Google Scholar] [CrossRef]
- Sudre, C.H.; Murray, B.; Varsavsky, T.; Graham, M.S.; Penfold, R.S.; Bowyer, R.C.; Pujol, J.C.; Klaser, K.; Antonelli, M.; Canas, L.S.; et al. Attributes and predictors of long COVID. Nat. Med. 2021, 27, 626–631. [Google Scholar] [CrossRef]
- Silva Andrade, B.; Siqueira, S.; de Assis Soares, W.R.; de Souza Rangel, F.; Santos, N.O.; Dos Santos Freitas, A.; Ribeiro da Silveira, P.; Tiwari, S.; Alzahrani, K.J.; Goes-Neto, A.; et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021, 13, 700. [Google Scholar] [CrossRef] [PubMed]
- Ahmad, M.S.; Shaik, R.A.; Ahmad, R.K.; Yusuf, M.; Khan, M.; Almutairi, A.B.; Alghuyaythat, W.K.Z.; Almutairi, S.B. “LONG COVID”: An insight. Eur. Rev. Med. Pharmacol. Sci. 2021, 25, 5561–5577. [Google Scholar] [PubMed]
- Michelen, M.; Manoharan, L.; Elkheir, N.; Cheng, V.; Dagens, A.; Hastie, C.; O’Hara, M.; Suett, J.; Dahmash, D.; Bugaeva, P.; et al. Characterising long COVID: A living systematic review. BMJ Glob. Health 2021, 6, e005427. [Google Scholar] [CrossRef] [PubMed]
- Lledo, G.M.; Sellares, J.; Brotons, C.; Sans, M.; Diez Anton, J.M.; Blanco, J.; Bassat, Q.; Sarukhan, A.; Miro, J.M.; de Sanjose, S.; et al. Post-acute COVID-19 syndrome (PACS): A new tsunami requiring a universal case definition. Clin. Microbiol. Infect. 2021; in press. [Google Scholar] [CrossRef] [PubMed]
- Garg, P.; Arora, U.; Kumar, A.; Wig, N. The “post-COVID” syndrome: How deep is the damage? J. Med. Virol. 2021, 93, 673–674. [Google Scholar] [CrossRef] [PubMed]
- Soriano, J.B.; Murthy, S.; Marshall, J.C.; Relan, P.; Diaz, J.V.; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2021. [Google Scholar] [CrossRef]
- Nalbandian, A.; Sehgal, K.; Gupta, A.; Madhavan, M.V.; McGroder, C.; Stevens, J.S.; Cook, J.R.; Nordvig, A.S.; Shalev, D.; Sehrawat, T.S.; et al. Post-acute COVID-19 syndrome. Nat. Med. 2021, 27, 601–615. [Google Scholar] [CrossRef]
- Gaebler, C.; Wang, Z.; Lorenzi, J.C.C.; Muecksch, F.; Finkin, S.; Tokuyama, M.; Cho, A.; Jankovic, M.; Schaefer-Babajew, D.; Oliveira, T.Y.; et al. Evolution of antibody immunity to SARS-CoV-2. Nature 2021, 591, 639–644. [Google Scholar] [CrossRef]
- de Melo, G.D.; Lazarini, F.; Levallois, S.; Hautefort, C.; Michel, V.; Larrous, F.; Verillaud, B.; Aparicio, C.; Wagner, S.; Gheusi, G.; et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021, 13, eabf8396. [Google Scholar] [CrossRef]
- Proal, A.D.; VanElzakker, M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021, 12, 698169. [Google Scholar] [CrossRef] [PubMed]
- Weinstock, L.B.; Brook, J.B.; Walters, A.S.; Goris, A.; Afrin, L.B.; Molderings, G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021, 112, 217–226. [Google Scholar] [CrossRef]
- Afrin, L.B.; Weinstock, L.B.; Molderings, G.J. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 2020, 100, 327–332. [Google Scholar] [CrossRef]
- Elrashdy, F.; Aljaddawi, A.A.; Redwan, E.M.; Uversky, V.N. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity. J. Biomol. Struct. Dyn. 2021, 39, 5831–5842. [Google Scholar] [CrossRef] [PubMed]
- Taboada, M.; Carinena, A.; Moreno, E.; Rodriguez, N.; Dominguez, M.J.; Casal, A.; Riveiro, V.; Diaz-Vieito, M.; Valdes, L.; Alvarez, J.; et al. Post-COVID-19 functional status six-months after hospitalization. J. Infect. 2021, 82, e31–e33. [Google Scholar] [CrossRef]
- Petersen, M.S.; Kristiansen, M.F.; Hanusson, K.D.; Danielsen, M.E.; Steig, B.A.; Gaini, S.; Strom, M.; Weihe, P. Long COVID in the Faroe Islands—A longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 2020, 73, e4058–e4063. [Google Scholar] [CrossRef] [PubMed]
- Parente-Arias, P.; Barreira-Fernandez, P.; Quintana-Sanjuas, A.; Patino-Castineira, B. Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019. Am. J. Otolaryngol. 2021, 42, 102648. [Google Scholar] [CrossRef] [PubMed]
- Baricich, A.; Borg, M.B.; Cuneo, D.; Cadario, E.; Azzolina, D.; Balbo, P.E.; Bellan, M.; Zeppegno, P.; Pirisi, M.; Cisari, C.; et al. Midterm functional sequelae and implications in rehabilitation after COVID-19: A cross-sectional study. Eur. J. Phys. Rehabil. Med. 2021, 57, 199–207. [Google Scholar] [CrossRef]
- Stavem, K.; Ghanima, W.; Olsen, M.K.; Gilboe, H.M.; Einvik, G. Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: A population-based cohort study. Thorax 2021, 76, 405–407. [Google Scholar] [CrossRef]
- Mazza, M.G.; Palladini, M.; De Lorenzo, R.; Magnaghi, C.; Poletti, S.; Furlan, R.; Ciceri, F.; COVID-19 BioB Outpatient Clinic Study Group; Rovere-Querini, P.; Benedetti, F. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021, 94, 138–147. [Google Scholar] [CrossRef]
- Jacobson, K.B.; Rao, M.; Bonilla, H.; Subramanian, A.; Hack, I.; Madrigal, M.; Singh, U.; Jagannathan, P.; Grant, P. Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale during a Global Pandemic. Clin. Infect. Dis. 2021, 73, e826–e829. [Google Scholar] [CrossRef]
- Einvik, G.; Dammen, T.; Ghanima, W.; Heir, T.; Stavem, K. Prevalence and Risk Factors for Post-Traumatic Stress in Hospitalized and Non-Hospitalized COVID-19 Patients. Int. J. Environ. Res. Public Health 2021, 18, 2079. [Google Scholar] [CrossRef]
- Ledford, H. Do vaccines protect against long COVID? What the data say. Nature 2021, 599, 546–548. [Google Scholar] [CrossRef] [PubMed]
- Antonelli, M.; Penfold, R.S.; Merino, J.; Sudre, C.H.; Molteni, E.; Berry, S.; Canas, L.S.; Graham, M.S.; Klaser, K.; Modat, M.; et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022, 22, 43–55. [Google Scholar] [CrossRef]
- Huang, C.; Huang, L.; Wang, Y.; Li, X.; Ren, L.; Gu, X.; Kang, L.; Guo, L.; Liu, M.; Zhou, X.; et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 2021, 397, 220–232. [Google Scholar] [CrossRef]
- Blanco, J.R.; Cobos-Ceballos, M.J.; Navarro, F.; Sanjoaquin, I.; Arnaiz de Las Revillas, F.; Bernal, E.; Buzon-Martin, L.; Viribay, M.; Romero, L.; Espejo-Perez, S.; et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin. Microbiol. Infect. 2021, 27, 892–896. [Google Scholar] [CrossRef]
- Galvan-Tejada, C.E.; Herrera-Garcia, C.F.; Godina-Gonzalez, S.; Villagrana-Banuelos, K.E.; Amaro, J.D.L.; Herrera-Garcia, K.; Rodriguez-Quinones, C.; Zanella-Calzada, L.A.; Ramirez-Barranco, J.; Avila, J.L.R.; et al. Persistence of COVID-19 Symptoms after Recovery in Mexican Population. Int. J. Environ. Res. Public Health 2020, 17, 9367. [Google Scholar] [CrossRef] [PubMed]
- Goertz, Y.M.J.; Van Herck, M.; Delbressine, J.M.; Vaes, A.W.; Meys, R.; Machado, F.V.C.; Houben-Wilke, S.; Burtin, C.; Posthuma, R.; Franssen, F.M.E.; et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020, 6, 542. [Google Scholar] [CrossRef] [PubMed]
- Garrigues, E.; Janvier, P.; Kherabi, Y.; Le Bot, A.; Hamon, A.; Gouze, H.; Doucet, L.; Berkani, S.; Oliosi, E.; Mallart, E.; et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020, 81, e4–e6. [Google Scholar] [CrossRef] [PubMed]
- Liang, L.; Yang, B.; Jiang, N.; Fu, W.; He, X.; Zhou, Y.; Ma, W.L.; Wang, X. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J. Korean Med. Sci. 2020, 35, e418. [Google Scholar] [CrossRef]
- Zhao, Y.M.; Shang, Y.M.; Song, W.B.; Li, Q.Q.; Xie, H.; Xu, Q.F.; Jia, J.L.; Li, L.M.; Mao, H.L.; Zhou, X.M.; et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 2020, 25, 100463. [Google Scholar] [CrossRef] [PubMed]
- Carfi, A.; Bernabei, R.; Landi, F.; The Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020, 324, 603–605. [Google Scholar] [CrossRef]
- Halpin, S.J.; McIvor, C.; Whyatt, G.; Adams, A.; Harvey, O.; McLean, L.; Walshaw, C.; Kemp, S.; Corrado, J.; Singh, R.; et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021, 93, 1013–1022. [Google Scholar] [CrossRef] [PubMed]
- Mason, R.J. Pathogenesis of COVID-19 from a cell biology perspective. Eur. Respir. J. 2020, 55, 2000607. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef][Green Version]
- Guan, W.J.; Ni, Z.Y.; Hu, Y.; Liang, W.H.; Ou, C.Q.; He, J.X.; Liu, L.; Shan, H.; Lei, C.L.; Hui, D.S.C.; et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020, 382, 1708–1720. [Google Scholar] [CrossRef] [PubMed]
- Li, X.; Zeng, W.; Li, X.; Chen, H.; Shi, L.; Li, X.; Xiang, H.; Cao, Y.; Chen, H.; Liu, C.; et al. CT imaging changes of corona virus disease 2019(COVID-19): A multi-center study in Southwest China. J. Transl. Med. 2020, 18, 154. [Google Scholar] [CrossRef][Green Version]
- Long, Q.; Li, J.; Hu, X.; Bai, Y.; Zheng, Y.; Gao, Z. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis. Front. Med. 2021, 8, 702635. [Google Scholar] [CrossRef]
- Cares-Marambio, K.; Montenegro-Jimenez, Y.; Torres-Castro, R.; Vera-Uribe, R.; Torralba, Y.; Alsina-Restoy, X.; Vasconcello-Castillo, L.; Vilaro, J. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chron. Respir. Dis. 2021, 18, 14799731211002240. [Google Scholar] [CrossRef] [PubMed]
- Lerum, T.V.; Aalokken, T.M.; Bronstad, E.; Aarli, B.; Ikdahl, E.; Lund, K.M.A.; Durheim, M.T.; Rodriguez, J.R.; Meltzer, C.; Tonby, K.; et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur. Respir. J. 2021, 57, 2003448. [Google Scholar] [CrossRef]
- Fogarty, H.; Townsend, L.; Morrin, H.; Ahmad, A.; Comerford, C.; Karampini, E.; Englert, H.; Byrne, M.; Bergin, C.; O’Sullivan, J.M.; et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 2021, 19, 2546–2553. [Google Scholar] [CrossRef]
- Froidure, A.; Mahsouli, A.; Liistro, G.; De Greef, J.; Belkhir, L.; Gerard, L.; Bertrand, A.; Koenig, S.; Pothen, L.; Yildiz, H.; et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir. Med. 2021, 181, 106383. [Google Scholar] [CrossRef] [PubMed]
- Cortes-Telles, A.; Lopez-Romero, S.; Figueroa-Hurtado, E.; Pou-Aguilar, Y.N.; Wong, A.W.; Milne, K.M.; Ryerson, C.J.; Guenette, J.A. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir. Physiol. Neurobiol. 2021, 288, 103644. [Google Scholar] [CrossRef] [PubMed]
- Gonzalez, J.; Benitez, I.D.; Carmona, P.; Santisteve, S.; Monge, A.; Moncusi-Moix, A.; Gort-Paniello, C.; Pinilla, L.; Carratala, A.; Zuil, M.; et al. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. Chest 2021, 160, 187–198. [Google Scholar] [CrossRef] [PubMed]
- van Gassel, R.J.J.; Bels, J.L.M.; Raafs, A.; van Bussel, B.C.T.; van de Poll, M.C.G.; Simons, S.O.; van der Meer, L.W.L.; Gietema, H.A.; Posthuma, R.; van Santen, S. High Prevalence of Pulmonary Sequelae at 3 Months after Hospital Discharge in Mechanically Ventilated Survivors of COVID-19. Am. J. Respir. Crit. Care Med. 2021, 203, 371–374. [Google Scholar] [CrossRef] [PubMed]
- Ojo, A.S.; Balogun, S.A.; Williams, O.T.; Ojo, O.S. Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies. Pulm. Med. 2020, 2020, 6175964. [Google Scholar] [CrossRef] [PubMed]
- McGroder, C.F.; Zhang, D.; Choudhury, M.A.; Salvatore, M.M.; D’Souza, B.M.; Hoffman, E.A.; Wei, Y.; Baldwin, M.R.; Garcia, C.K. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax 2021, 76, 1242–1245. [Google Scholar] [CrossRef]
- Wu, X.; Liu, X.; Zhou, Y.; Yu, H.; Li, R.; Zhan, Q.; Ni, F.; Fang, S.; Lu, Y.; Ding, X.; et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021, 9, 747–754. [Google Scholar] [CrossRef]
- Myall, K.J.; Mukherjee, B.; Castanheira, A.M.; Lam, J.L.; Benedetti, G.; Mak, S.M.; Preston, R.; Thillai, M.; Dewar, A.; Molyneaux, P.L.; et al. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Ann. Am. Thorac. Soc. 2021, 18, 799–806. [Google Scholar] [CrossRef]
- Udwadia, Z.F.; Pokhariyal, P.K.; Tripathi, A.K.R.; Kohli, A. Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids. Lung India 2021, 38 (Suppl. S1), S61–S63. [Google Scholar] [CrossRef] [PubMed]
- George, P.M.; Wells, A.U.; Jenkins, R.G. Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy. Lancet Respir. Med. 2020, 8, 807–815. [Google Scholar] [CrossRef]
- Udwadia, Z.F.; Koul, P.A.; Richeldi, L. Post-COVID lung fibrosis: The tsunami that will follow the earthquake. Lung India 2021, 38 (Suppl. S1), S41–S47. [Google Scholar] [CrossRef]
- Li, Y.; Li, H.; Liu, S.; Pan, P.; Su, X.; Tan, H.; Wu, D.; Zhang, L.; Song, C.; Dai, M.; et al. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Mol. Immunol. 2018, 99, 134–144. [Google Scholar] [CrossRef] [PubMed]
- Rai, D.K.; Sharma, P.; Kumar, R. Post COVID 19 pulmonary fibrosis. Is it real threat? Indian J. Tuberc. 2021, 68, 330–333. [Google Scholar] [CrossRef] [PubMed]
- Ulrich, H.; Pillat, M.M. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement. Stem Cell Rev. Rep. 2020, 16, 434–440. [Google Scholar] [CrossRef]
- Spruit, M.A.; Holland, A.E.; Singh, S.J.; Tonia, T.; Wilson, K.C.; Troosters, T. COVID-19: Interim Guidance on Rehabilitation in the Hospital and Post-Hospital Phase from a European Respiratory Society and American Thoracic Society-coordinated International Task Force. Eur. Respir. J. 2020, 56, 2002197. [Google Scholar] [CrossRef]
- Bangalore, S.; Sharma, A.; Slotwiner, A.; Yatskar, L.; Harari, R.; Shah, B.; Ibrahim, H.; Friedman, G.H.; Thompson, C.; Alviar, C.L.; et al. ST-Segment Elevation in Patients with COVID-19—A Case Series. N. Engl. J. Med. 2020, 382, 2478–2480. [Google Scholar] [CrossRef]
- Inciardi, R.M.; Lupi, L.; Zaccone, G.; Italia, L.; Raffo, M.; Tomasoni, D.; Cani, D.S.; Cerini, M.; Farina, D.; Gavazzi, E.; et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020, 5, 819–824. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Doyen, D.; Moceri, P.; Ducreux, D.; Dellamonica, J. Myocarditis in a patient with COVID-19: A cause of raised troponin and ECG changes. Lancet 2020, 395, 1516. [Google Scholar] [CrossRef]
- van Osch, D.; Asselbergs, F.W.; Teske, A.J. Takotsubo cardiomyopathy in COVID-19: A case report. Haemodynamic and therapeutic considerations. Eur. Heart J. Case Rep. 2020, 4, 1–6. [Google Scholar] [CrossRef] [PubMed]
- Chitsazan, M.; Amin, A.; Chitsazan, M.; Ziaie, N.; Amri Maleh, P.; Pouraliakbar, H.; Von Haehling, S. Heart failure with preserved ejection fraction in coronavirus disease 2019 patients: The promising role of diuretic therapy in critically ill patients. ESC Heart Fail. 2021, 8, 1610–1614. [Google Scholar] [CrossRef] [PubMed]
- Jirak, P.; Larbig, R.; Shomanova, Z.; Frob, E.J.; Dankl, D.; Torgersen, C.; Frank, N.; Mahringer, M.; Butkiene, D.; Haake, H.; et al. Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: Results from a multicentre study. ESC Heart Fail. 2021, 8, 37–46. [Google Scholar] [CrossRef] [PubMed]
- Petersen, S.E.; Friedrich, M.G.; Leiner, T.; Elias, M.D.; Ferreira, V.M.; Fenski, M.; Flamm, S.D.; Fogel, M.; Garg, R.; Halushka, M.K.; et al. Cardiovascular Magnetic Resonance for Patients with COVID-19. JACC Cardiovasc. Imaging, 2021; in press. [Google Scholar] [CrossRef]
- Lindner, D.; Fitzek, A.; Brauninger, H.; Aleshcheva, G.; Edler, C.; Meissner, K.; Scherschel, K.; Kirchhof, P.; Escher, F.; Schultheiss, H.P.; et al. Association of Cardiac Infection with SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020, 5, 1281–1285. [Google Scholar] [CrossRef]
- Siripanthong, B.; Nazarian, S.; Muser, D.; Deo, R.; Santangeli, P.; Khanji, M.Y.; Cooper, L.T., Jr.; Chahal, C.A.A. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 2020, 17, 1463–1471. [Google Scholar] [CrossRef] [PubMed]
- Wu, Q.; Zhou, L.; Sun, X.; Yan, Z.; Hu, C.; Wu, J.; Xu, L.; Li, X.; Liu, H.; Yin, P.; et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci. Rep. 2017, 7, 9110. [Google Scholar] [CrossRef]
- Ziegler, C.G.K.; Allon, S.J.; Nyquist, S.K.; Mbano, I.M.; Miao, V.N.; Tzouanas, C.N.; Cao, Y.; Yousif, A.S.; Bals, J.; Hauser, B.M.; et al. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell 2020, 181, 1016–1035.e19. [Google Scholar] [CrossRef]
- Reynolds, H.R.; Adhikari, S.; Pulgarin, C.; Troxel, A.B.; Iturrate, E.; Johnson, S.B.; Hausvater, A.; Newman, J.D.; Berger, J.S.; Bangalore, S.; et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of COVID-19. N. Engl. J. Med. 2020, 382, 2441–2448. [Google Scholar] [CrossRef]
- Fried, J.A.; Ramasubbu, K.; Bhatt, R.; Topkara, V.K.; Clerkin, K.J.; Horn, E.; Rabbani, L.; Brodie, D.; Jain, S.S.; Kirtane, A.J.; et al. The Variety of Cardiovascular Presentations of COVID-19. Circulation 2020, 141, 1930–1936. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Liu, P.P.; Blet, A.; Smyth, D.; Li, H. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation 2020, 142, 68–78. [Google Scholar] [CrossRef][Green Version]
- Mills, R.J.; Humphrey, S.J.; Fortuna, P.R.J.; Lor, M.; Foster, S.R.; Quaife-Ryan, G.A.; Johnston, R.L.; Dumenil, T.; Bishop, C.; Rudraraju, R.; et al. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection. Cell 2021, 184, 2167–2182.e22. [Google Scholar] [CrossRef] [PubMed]
- Robson, A. Preventing cardiac damage in patients with COVID-19. Nat. Rev. Cardiol. 2021, 18, 387. [Google Scholar] [CrossRef]
- Puntmann, V.O.; Carerj, M.L.; Wieters, I.; Fahim, M.; Arendt, C.; Hoffmann, J.; Shchendrygina, A.; Escher, F.; Vasa-Nicotera, M.; Zeiher, A.M.; et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020, 5, 1265–1273. [Google Scholar] [CrossRef]
- Kopanczyk, R.; Kumar, N.; Papadimos, T. Post-Acute COVID-19 Syndrome for Anesthesiologists: A Narrative Review and a Pragmatic Approach to Clinical Care. J. Cardiothorac. Vasc. Anesth. 2021; in press. [Google Scholar] [CrossRef]
- Li, X.; Pan, X.; Li, Y.; An, N.; Xing, Y.; Yang, F.; Tian, L.; Sun, J.; Gao, Y.; Shang, H.; et al. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: A meta-analysis and systematic review. Crit. Care 2020, 24, 468. [Google Scholar] [CrossRef] [PubMed]
- Shi, S.; Qin, M.; Shen, B.; Cai, Y.; Liu, T.; Yang, F.; Gong, W.; Liu, X.; Liang, J.; Zhao, Q.; et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020, 5, 802–810. [Google Scholar] [CrossRef][Green Version]
- Nabors, C.; Sridhar, A.; Hooda, U.; Lobo, S.A.; Levine, A.; Frishman, W.H.; Dhand, A. Characteristics and Outcomes of Patients 80 Years and Older Hospitalized With Coronavirus Disease 2019 (COVID-19). Cardiol. Rev. 2021, 29, 39–42. [Google Scholar] [CrossRef] [PubMed]
- Radin, J.M.; Quer, G.; Ramos, E.; Baca-Motes, K.; Gadaleta, M.; Topol, E.J.; Steinhubl, S.R. Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection. JAMA Netw. Open 2021, 4, e2115959. [Google Scholar] [CrossRef] [PubMed]
- Wong, S.W.; Fan, B.E.; Huang, W.; Chia, Y.W. ST-segment elevation myocardial infarction in post-COVID-19 patients: A case series. Ann. Acad. Med. Singap. 2021, 50, 425–430. [Google Scholar] [CrossRef]
- Ishibashi, Y.; Yoneyama, K.; Tsuchida, T.; Akashi, Y.J. Post-COVID-19 Postural Orthostatic Tachycardia Syndrome. Intern. Med. 2021, 60, 2345. [Google Scholar] [CrossRef] [PubMed]
- Johansson, M.; Stahlberg, M.; Runold, M.; Nygren-Bonnier, M.; Nilsson, J.; Olshansky, B.; Bruchfeld, J.; Fedorowski, A. Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience. JACC Case Rep. 2021, 3, 573–580. [Google Scholar] [CrossRef] [PubMed]
- Satake, K.; Hongo, M.; Ujiie, H.; Okuno, Y.; Goto, Y. The effect of cisapride on intestinal transit. Nihon Heikatsukin Gakkai Zasshi 1988, 24, 55–60. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Bende, F.; Tudoran, C.; Sporea, I.; Fofiu, R.; Baldea, V.; Cotrau, R.; Popescu, A.; Sirli, R.; Ungureanu, B.S.; Tudoran, M. A Multidisciplinary Approach to Evaluate the Presence of Hepatic and Cardiac Abnormalities in Patients with Post-Acute COVID-19 Syndrome-A Pilot Study. J. Clin. Med. 2021, 10, 2507. [Google Scholar] [CrossRef]
- Tudoran, C.; Tudoran, M.; Pop, G.N.; Giurgi-Oncu, C.; Cut, T.G.; Lazureanu, V.E.; Oancea, C.; Parv, F.; Ciocarlie, T.; Bende, F. Associations between the Severity of the Post-Acute COVID-19 Syndrome and Echocardiographic Abnormalities in Previously Healthy Outpatients Following Infection with SARS-CoV-2. Biology 2021, 10, 469. [Google Scholar] [CrossRef] [PubMed]
- Sonnweber, T.; Sahanic, S.; Pizzini, A.; Luger, A.; Schwabl, C.; Sonnweber, B.; Kurz, K.; Koppelstatter, S.; Haschka, D.; Petzer, V.; et al. Cardiopulmonary recovery after COVID-19: An observational prospective multicentre trial. Eur. Respir. J. 2021, 57, 2003481. [Google Scholar] [CrossRef]
- Arevalos, V.; Ortega-Paz, L.; Fernandez-Rodriguez, D.; Alfonso Jimenez-Diaz, V.; Rius, J.B.; Campo, G.; Rodriguez-Santamarta, M.; de Prado, A.P.; Gomez-Menchero, A.; Diaz Fernandez, J.F.; et al. Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol. PLoS ONE 2021, 16, e0255263. [Google Scholar] [CrossRef] [PubMed]
- Serrano-Castro, P.J.; Estivill-Torrus, G.; Cabezudo-Garcia, P.; Reyes-Bueno, J.A.; Ciano Petersen, N.; Aguilar-Castillo, M.J.; Suarez-Perez, J.; Jimenez-Hernandez, M.D.; Moya-Molina, M.A.; Oliver-Martos, B.; et al. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic? Neurologia 2020, 35, 245–251. [Google Scholar] [CrossRef] [PubMed]
- Ellul, M.A.; Benjamin, L.; Singh, B.; Lant, S.; Michael, B.D.; Easton, A.; Kneen, R.; Defres, S.; Sejvar, J.; Solomon, T. Neurological associations of COVID-19. Lancet Neurol. 2020, 19, 767–783. [Google Scholar] [CrossRef]
- Wijeratne, T.; Crewther, S. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J. Neurol. Sci. 2020, 419, 117179. [Google Scholar] [CrossRef] [PubMed]
- Nersesjan, V.; Amiri, M.; Lebech, A.M.; Roed, C.; Mens, H.; Russell, L.; Fonsmark, L.; Berntsen, M.; Sigurdsson, S.T.; Carlsen, J.; et al. Central and peripheral nervous system complications of COVID-19: A prospective tertiary center cohort with 3-month follow-up. J. Neurol. 2021, 268, 3086–3104. [Google Scholar] [CrossRef] [PubMed]
- Raciti, L.; Calabro, R.S. Neurological complications of COVID-19: From pathophysiology to rehabilitation. An overview. Acta Biomed. 2021, 92, e2021317. [Google Scholar] [PubMed]
- Heneka, M.T.; Golenbock, D.; Latz, E.; Morgan, D.; Brown, R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res. Ther. 2020, 12, 69. [Google Scholar] [CrossRef]
- Zhou, Z.; Kang, H.; Li, S.; Zhao, X. Understanding the neurotropic characteristics of SARS-CoV-2: From neurological manifestations of COVID-19 to potential neurotropic mechanisms. J. Neurol. 2020, 267, 2179–2184. [Google Scholar] [CrossRef] [PubMed]
- Zubair, A.S.; McAlpine, L.S.; Gardin, T.; Farhadian, S.; Kuruvilla, D.E.; Spudich, S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020, 77, 1018–1027. [Google Scholar] [CrossRef]
- Matschke, J.; Lutgehetmann, M.; Hagel, C.; Sperhake, J.P.; Schroder, A.S.; Edler, C.; Mushumba, H.; Fitzek, A.; Allweiss, L.; Dandri, M.; et al. Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 2020, 19, 919–929. [Google Scholar] [CrossRef]
- Renaud-Charest, O.; Lui, L.M.W.; Eskander, S.; Ceban, F.; Ho, R.; Di Vincenzo, J.D.; Rosenblat, J.D.; Lee, Y.; Subramaniapillai, M.; McIntyre, R.S. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J. Psychiatr. Res. 2021, 144, 129–137. [Google Scholar] [CrossRef] [PubMed]
- Bo, H.X.; Li, W.; Yang, Y.; Wang, Y.; Zhang, Q.; Cheung, T.; Wu, X.; Xiang, Y.T. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol. Med. 2021, 51, 1052–1053. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Lorkiewicz, P.; Waszkiewicz, N. Biomarkers of Post-COVID Depression. J. Clin. Med. 2021, 10, 4142. [Google Scholar] [CrossRef]
- Guo, Q.; Zheng, Y.; Shi, J.; Wang, J.; Li, G.; Li, C.; Fromson, J.A.; Xu, Y.; Liu, X.; Xu, H.; et al. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study. Brain Behav. Immun. 2020, 88, 17–27. [Google Scholar] [CrossRef]
- Cai, X.; Hu, X.; Ekumi, I.O.; Wang, J.; An, Y.; Li, Z.; Yuan, B. Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups. Am. J. Geriatr. Psychiatry 2020, 28, 1030–1039. [Google Scholar] [CrossRef]
- Mazza, M.G.; De Lorenzo, R.; Conte, C.; Poletti, S.; Vai, B.; Bollettini, I.; Melloni, E.M.T.; Furlan, R.; Ciceri, F.; Rovere-Querini, P.; et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav. Immun. 2020, 89, 594–600. [Google Scholar] [CrossRef]
- Bottemanne, H.; Gouraud, C.; Hulot, J.S.; Blanchard, A.; Ranque, B.; Lahlou-Laforet, K.; Limosin, F.; Gunther, S.; Lebeaux, D.; Lemogne, C. Do Anxiety and Depression Predict Persistent Physical Symptoms After a Severe COVID-19 Episode? A Prospective Study. Front. Psychiatry 2021, 12, 757685. [Google Scholar] [CrossRef]
- Kadimpati, S.; Zale, E.L.; Hooten, M.W.; Ditre, J.W.; Warner, D.O. Associations between Neuroticism and Depression in Relation to Catastrophizing and Pain-Related Anxiety in Chronic Pain Patients. PLoS ONE 2015, 10, e0126351. [Google Scholar]
- O’Keefe, E.L.; Torres-Acosta, N.; O’Keefe, J.H.; Sturgess, J.E.; Lavie, C.J.; Bybee, K.A. Takotsubo Syndrome: Cardiotoxic Stress in the COVID Era. Mayo Clin. Proc. Innov. Qual. Outcomes 2020, 4, 775–785. [Google Scholar] [CrossRef] [PubMed]
- Becker, R.C. Autonomic dysfunction in SARS-CoV-2 infection acute and long-term implications COVID-19 editor’s page series. J. Thromb. Thrombolysis 2021, 52, 692–707. [Google Scholar] [CrossRef]
- Stockelman, K.A.; Bain, A.R.; Dow, C.A.; Diehl, K.J.; Greiner, J.J.; Stauffer, B.L.; DeSouza, C.A. Regular aerobic exercise counteracts endothelial vasomotor dysfunction associated with insufficient sleep. Am. J. Physiol. Heart Circ. Physiol. 2021, 320, H1080–H1088. [Google Scholar] [CrossRef]
- Higgins, V.; Sohaei, D.; Diamandis, E.P.; Prassas, I. COVID-19: From an acute to chronic disease? Potential long-term health consequences. Crit. Rev. Clin. Lab. Sci. 2021, 58, 297–310. [Google Scholar] [CrossRef] [PubMed]
- Mancini, D.M.; Brunjes, D.L.; Lala, A.; Trivieri, M.G.; Contreras, J.P.; Natelson, B.H. Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post-Coronavirus Disease. JACC Heart Fail. 2021, 9, 927–937. [Google Scholar] [CrossRef]
- Greenhalgh, T.; Knight, M.; A’Court, C.; Buxton, M.; Husain, L. Management of post-acute COVID-19 in primary care. BMJ 2020, 370, m3026. [Google Scholar] [CrossRef] [PubMed]
- Grigoletto, I.; Cavalheri, V.; Lima, F.F.; Ramos, E.M.C. Recovery after COVID-19: The potential role of pulmonary rehabilitation. Braz. J. Phys. Ther. 2020, 24, 463–464. [Google Scholar] [CrossRef] [PubMed]
- Candan, S.A.; Elibol, N.; Abdullahi, A. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19. Physiother. Theory Pract. 2020, 36, 663–668. [Google Scholar] [CrossRef] [PubMed]
- Poyraz, B.C.; Poyraz, C.A.; Olgun, Y.; Gurel, O.; Alkan, S.; Ozdemir, Y.E.; Balkan, I.I.; Karaali, R. Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Res. 2021, 295, 113604. [Google Scholar] [CrossRef] [PubMed]
- Kamal, M.; Abo Omirah, M.; Hussein, A.; Saeed, H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2021, 75, e13746. [Google Scholar] [CrossRef] [PubMed]
- Raveendran, A.V.; Jayadevan, R.; Sashidharan, S. Long COVID: An overview. Diabetes Metab. Syndr. 2021, 15, 869–875. [Google Scholar] [CrossRef] [PubMed]
- Raghu, G.; Wilson, K.C. COVID-19 interstitial pneumonia: Monitoring the clinical course in survivors. Lancet Respir. Med. 2020, 8, 839–842. [Google Scholar] [CrossRef]
- Lassau, N.; Ammari, S.; Chouzenoux, E.; Gortais, H.; Herent, P.; Devilder, M.; Soliman, S.; Meyrignac, O.; Talabard, M.P.; Lamarque, J.P.; et al. Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients. Nat. Commun. 2021, 12, 634. [Google Scholar] [CrossRef] [PubMed]
- Basch, E.; Deal, A.M.; Dueck, A.C.; Scher, H.I.; Kris, M.G.; Hudis, C.; Schrag, D. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA 2017, 318, 197–198. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Burgers, J. “Long COVID”: The Dutch response. BMJ 2020, 370, m3202. [Google Scholar] [CrossRef]
System Involved | Symptoms | Monitoring System |
---|---|---|
Cardiovascular complications |
|
|
Respiratory complications |
|
|
Nervous system complications |
|
|
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Visco, V.; Vitale, C.; Rispoli, A.; Izzo, C.; Virtuoso, N.; Ferruzzi, G.J.; Santopietro, M.; Melfi, A.; Rusciano, M.R.; Maglio, A.; et al. Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems. J. Clin. Med. 2022, 11, 524. https://doi.org/10.3390/jcm11030524
Visco V, Vitale C, Rispoli A, Izzo C, Virtuoso N, Ferruzzi GJ, Santopietro M, Melfi A, Rusciano MR, Maglio A, et al. Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems. Journal of Clinical Medicine. 2022; 11(3):524. https://doi.org/10.3390/jcm11030524
Chicago/Turabian StyleVisco, Valeria, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso, Germano Junior Ferruzzi, Mario Santopietro, Americo Melfi, Maria Rosaria Rusciano, Angelantonio Maglio, and et al. 2022. "Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems" Journal of Clinical Medicine 11, no. 3: 524. https://doi.org/10.3390/jcm11030524